Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists represent a major advancement in weight management and diabetes care, with clinical trials showing average weight loss of 15–22% of body weight over 68 weeks. These medications work by activating receptors in your brain and pancreas that regulate hunger, fullness signals, and blood sugar levels. PlexusDx offers multiple GLP-1 and GLP-1/GIP combination medications compounded by licensed 503A pharmacies to serve patients across all 50 states.
How GLP-1 Receptor Agonists Work in Your Body
Glucagon-like peptide-1 (GLP-1) is a natural hormone your intestines release after eating. It tells your brain you are full, slows stomach emptying, and signals your pancreas to release insulin when blood sugar rises. GLP-1 receptor agonists are medications that mimic this hormone's action, binding to GLP-1 receptors on nerve cells and pancreatic cells. By amplifying these signals, the medications reduce appetite, lower cravings for high-calorie foods, and help stabilize blood sugar throughout the day.
The mechanism extends beyond appetite suppression. GLP-1 agonists also improve how your body handles glucose by increasing insulin secretion when blood sugar is elevated and decreasing glucagon (a hormone that raises blood sugar). This dual action makes them effective for both weight loss and type 2 diabetes management. Studies show that consistent use leads to changes in how your brain perceives food reward, making it easier to maintain lower calorie intake without constant willpower.
Injectable vs. Oral GLP-1 Medications: Key Differences
PlexusDx offers both injectable and oral forms of GLP-1 agonists. Injectable semaglutide starts at $149 per month and is administered once weekly under the skin, delivering consistent medication levels that many patients find easier to manage than daily pills. Oral semaglutide begins at $249 per month and is taken daily on an empty stomach, offering convenience for patients who prefer to avoid injections.
Tirzepatide, a more recent advancement, acts on both GLP-1 and GIP receptors, often producing greater weight loss than semaglutide alone. PlexusDx compounded tirzepatide injection starts at $249 per month, while oral tirzepatide begins at $279 per month. For patients seeking maximum benefit, PlexusDx GLP-Squared combines semaglutide and tirzepatide in a single injection starting at $249 per month. Your dose may need to go up. Your price won't—PlexusDx pricing remains flat across all dose levels.
FDA-Approved GLP-1 Medications vs. Compounded Options
The FDA has approved brand-name semaglutide (Ozempic for diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro for diabetes, Zepbound for weight loss). These brand medications are often expensive and subject to insurance approval delays or denials. PlexusDx partners with licensed 503A compounding pharmacies to prepare customized medications that match the same active pharmaceutical ingredients, allowing for faster access and lower costs without insurance barriers.
Compounded medications from 503A pharmacies are not FDA-approved in the traditional sense, but they are legally manufactured under strict pharmacy regulations and quality standards. PlexusDx serves all 50 states with no insurance requirement and no membership fees, making treatment accessible whether you have coverage or not. HSA and FSA accounts are accepted, and the Precision Peptide Genetic Test ($99 add-on after the first month) can help identify which peptide pathway is most likely to work for your genetics.
Personalized GLP-1 Treatment and Genetic Insights
Not all patients respond equally to GLP-1 agonists, even at the same dose. Genetic variations in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) influence how strongly you respond to these medications and how much weight you may lose. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to predict your individual response profile.
By understanding your genetic predisposition, PlexusDx can recommend which medication—semaglutide, tirzepatide, or GLP-Squared dual-compound—is most likely to match your biology. This precision approach reduces trial-and-error prescribing and helps you achieve results faster. Patients with specific genetic variants may benefit from GLP-1/GIP dual agonists, while others may see optimal results with single-pathway medications. The genetic test is offered as an affordable add-on after your first month of treatment, allowing you to refine your therapy based on science, not guesswork.
Common Side Effects and Safety Considerations
The most commonly reported side effects of GLP-1 agonists are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These effects typically appear during dose escalation and decrease as your body adjusts over 2–4 weeks. Eating smaller meals, staying hydrated, and avoiding high-fat foods can reduce nausea. Serious side effects are rare but may include pancreatitis (inflammation of the pancreas) or gallbladder issues, which require immediate medical attention if you experience severe abdominal pain.
PlexusDx requires a consultation with a licensed healthcare provider before starting any medication to ensure GLP-1 agonists are appropriate for your health history. Certain medical conditions, such as a personal or family history of thyroid cancer or multiple endocrine neoplasia, may make these medications unsuitable. Patients with type 1 diabetes should not use GLP-1 agonists without specialized medical oversight. Your PlexusDx provider will review your full medical background and monitor your progress throughout treatment to maximize safety and results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between semaglutide and tirzepatide?
Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors. Studies show tirzepatide often produces 20–25% greater weight loss than semaglutide alone. PlexusDx offers compounded semaglutide starting at $149/month (injection) or $249/month (oral), and tirzepatide starting at $249/month (injection) or $279/month (oral).
How quickly will I see weight loss results with GLP-1 medications?
Most patients notice reduced appetite within 3–7 days of starting a GLP-1 agonist. Measurable weight loss typically appears within 2–4 weeks, with cumulative loss accelerating over 8–12 weeks. Clinical trial data shows average weight loss of 5–10% of body weight by 12 weeks and 15–22% by 68 weeks with consistent use and lifestyle support.
Can I use PlexusDx medications if I don't have insurance?
Yes. PlexusDx serves all 50 states with no insurance requirement, no membership fees, and no prior-authorization delays. Your dose may need to go up. Your price won't—all medications are flat-rate pricing starting at $149/month for compounded semaglutide injection. HSA and FSA funds are accepted for eligible accounts.
Are compounded GLP-1 medications as safe as FDA-approved brands?
PlexusDx medications are compounded by licensed 503A pharmacies under strict state and federal quality standards. While not FDA-approved, they contain the same active pharmaceutical ingredients as brand medications and follow rigorous manufacturing protocols. All PlexusDx patients receive a medical consultation before treatment and ongoing provider monitoring to ensure safety.
How does the Precision Peptide Genetic Test help personalize my treatment?
The $99 Precision Peptide Genetic Test analyzes four key genes (GLP1R, GIPR, FTO, MC4R) and maps 150+ genetic insights across 14 metabolic pathways to predict your response to GLP-1 agonists, tirzepatide, and combination therapies. This allows PlexusDx to recommend the medication most likely to work for your specific biology, available as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Can I Lose on Semaglutide Injections?
How Much Weight Can I Lose on Zepbound?